Drawing for AVANOS

USPTO serial 88027718

AVANOS

Reviewed by CopyMark Law Group

Reg. 6725106Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
FIRST, VIVIAN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AVANOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrea E. Bates

Andrea E. Bates BATES & BATES, LLC1890 MARIETTA BLVD NWATLANTA, GA 30318UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Adhesive strip wound closures; wound dressings; preparations for sealing skin for protection from bacteria into an opening in the skin, namely, liquid film-forming sealants; diagnostic preparations for medical purposes for detection of gastro-intestinal disease; non-invasive breath tests for stomach wall infectionsACTIVE—
010Medical apparatus and instruments for use in surgery; Medical and surgical apparatus and instruments, namely, paracentesis trays and structural components therefor; paracentesis trays containing iodine swab sticks, all sold as a unit; medical instruments and cables for use in radiofrequency ablation; surgical instruments for use in the musculoskeletal system, namely, cannulae, probes, and sheaths, and water-cooled components, namely, probes, introducers, burettes, measuring and positioning devices; cooled radio frequency probes for denervation in treatment of chronic joint pain; endoscopic equipment, namely, brushes, handles, snares, and sponges, retrieval baskets, and retrieval hoods; probes and needles for medical use; medical syringes; sutures; scalpels; guide wires for positioning medical equipment; Medical and surgical infusion apparatus, namely, infusion pumps; Medical apparatus for intravenous administration of fluids or drugs, namely, infusion pumps, valves, and infusion sets; medical apparatus, namely, medical pumps for controlled infusion of medication and liquid; Intravenous apparatus wrist supports and straps; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; infusion sets; Medical and surgical catheters, and parts and fittings therefor; Medical and therapeutic ice packs; Tracheal ventilating and aspirating apparatus and kits comprised thereof; Endotracheal tubes; Medical instruments for percutaneous tracheostomy and structural components therefor; Humidification devices for medical purposes; Medical ventilators, and tubing and tubing connectors therefor; Introducers, guide wires and locking mechanisms for tracheal ventilating apparatus; Nasal dilators; Kits containing all of the above medical devices for use in medical and surgical procedures; Medical devices for administering nutritional supplements and medication, namely, medical tubing, adapters, caps and/or accessories therefor, namely, replacement caps, injection caps and pressure cuffs; Enteral feeding pumps and tubes and placement kits therefor; Medical apparatus and instruments for monitoring the nutrition levels of patients; Gastric lavage kits containing lavage devices, tubes and bags for pumping stomachs; Pain management systems, namely, electronic stimulator for use within the musculoskeletal system; high frequency electromagnetic therapy apparatus; kits comprised of water-cooled components, namely, probes, introducers, burettes, measuring and positioning devices, for medical use within the musculoskeletal system; Probes and patient monitoring sensors utilizing water cooled radio frequency for pain management relating to disc treatment; Nerve stimulator apparatus for use in stimulating nerve function for medical purpose and/or surgical treatment, and parts and fittings therefor; Nerve locator apparatus for use in locating and identifying nerve function for medical purpose and/or surgical treatment, and parts and fittings therefor; Pain management kits comprising needles for injections and catheter placement, medical syringes for injections, catheters, medical utility drapes, namely, ultrasound drapes, medical gauze, trays for medical use, and ultrasound imaging accessories, namely, ultrasound probe for medical use and ultrasound gelACTIVEJun 30, 2018
044Providing information in the fields of health and medical careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 6, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 5, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 21, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 14, 2022IUAFUSE AMENDMENT FILED—
Mar 14, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 22, 2021EX5GSOU EXTENSION 5 GRANTED—
Sep 22, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 20, 2021EXT5SOU EXTENSION 5 FILED—
Sep 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 12, 2021EX4GSOU EXTENSION 4 GRANTED—
Mar 12, 2021EXT4SOU EXTENSION 4 FILED—
Mar 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 15, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 15, 2020EXT3SOU EXTENSION 3 FILED—
Sep 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 19, 2020EX2GSOU EXTENSION 2 GRANTED—
Mar 19, 2020EXT2SOU EXTENSION 2 FILED—
Mar 19, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 21, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 19, 2019EX1GSOU EXTENSION 1 GRANTED—
Sep 19, 2019EXT1SOU EXTENSION 1 FILED—
Sep 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 19, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 22, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 22, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 10, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 10, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 10, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 4, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 27, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 10, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 10, 2018ALIEASSIGNED TO LIE—
Oct 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 26, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Oct 26, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 26, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 26, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 25, 2018DOCKASSIGNED TO EXAMINER—
Jul 13, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance